4.2 Efficacy and Safety: Ozempic has demonstrated impressive efficacy in clinical trials, effectively reducing HbA1c levels and promoting weight loss
Consistent with this position, neither the FDA nor EMA [45, 46] has found evidence that GLP-1 RAs increase suicidal thoughts or behavior but advises ongoing monitoring as a precaution
Using weighted correlation network analysis (WGCNA) 34 , we identified a key gene module that was both upregulated by LPS (BH-adjusted P =0.014) and suppressed by semaglutide treatment during the resolution phase (BH-adjusted P =0.018, Fig
And thats a change from where weve been in terms of treating obesity. For practitioners looking to deepen their expertise in GLP-1 medications, IAPAM offers specialized training programs designed to help physicians understand and integrate these therapies into their aesthetic medicine practices
Side Effects and Tolerability Both medications can cause gastrointestinal side effects such as nausea, bloating, or reflux